All news

BlackRock reports 338,133 shares in Monopar Therapeutics (MNPR).

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

BlackRock, Inc. has reported a beneficial ownership of 338,133 common shares, representing a 5.03% stake in Monopar Therapeutics (MNPR). This Schedule 13G filing indicates that BlackRock holds sole voting power over 330,149 shares and sole dispositive power over 338,133 shares, with no shared voting or dispositive power.

Read original source

MNPR company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.